Your support helps us to tell the story
As your White House correspondent, I ask the tough questions and seek the answers that matter.
Your support enables me to be in the room, pressing for transparency and accountability. Without your contributions, we wouldn't have the resources to challenge those in power.
Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election
![Head shot of Andrew Feinberg](https://static.independent.co.uk/static-assets/support-us/andrew-feinberg.png)
Andrew Feinberg
White House Correspondent
India’s southern state of Andhra Pradesh wrapped up rescue work on Thursday at a pharmaceutical manufacturing plant where an explosion the previous day killed 17 people, a senior state official said.
The incident at privately held Escientia Advanced Sciences in Anakapalli district was the state’s worst such in recent years.
Nearly 40 people were injured and rescue operations had been completed, industries secretary N Yuvaraj told Reuters.
Escientia did not immediately respond to a request for comment, but government officials said they suspected an explosion in the chemical reactor.
Authorities said they were scanning CCTV footage and questioning the injured to decide if human error was responsible for the blast.
A preliminary investigation showed “there was some vapour leak that led to chemical reactions which caused the explosion”, said Yuvaraj, who identified the solvent involved as methyl tert-butyl ether.
In a post on X, prime minister Narendra Modi offered condolences to the relatives of the dead.
India, known as the pharmacy of the world, is home to many plants that make pharmaceuticals.
A fire in the same district last year in a unit of Sahithi Pharma killed two people and injured five.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments